Standard Median Nerve Ultrasound in Carpal Tunnel Syndrome: a Retrospective Review of 1,021 Cases

Guide DISCLOSURE APPENDIX This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The AANEM is accredited by the ACCME to provide continuing medical education for physicians. It is the policy of the AANEM to ensure balance, independence, objectivity and scientific rigor in all of its educational activities. All participating speakers, planning committee members, and authors are required to disclose to the program audience any financial relationships with proprietary entities, producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients that is related to the subject matter of this program. Spouse/partner relationships with commercial interests are also disclosed. Disclosure information was reviewed in advance in order to manage and resolve any possible conflicts of interest. All conflicts of interest have been resolved in accordance with ACCME Standards for Commercial SupportSM. Poster Sessions Disclosure Information Specific disclosure information for abstract authors and planning committee members with relevant financial relationships to the poster sessions is listed below. Abstract authors, planning committee members, and all other individuals in control of content for the poster sessions that are not included in the Disclosure Appendix, had no relevant financial relationships to disclose. Last Name First Name Abstract No. Degree(s) Financial Relationship Commercial Interest Ales Kathy 6 MD Employee Jacobus Pharmaceutical Company, Inc Allen Jeffrey 3, 15 MD Research Funding Grifols Allen Jeffrey 3, 15 MD Research Funding CSL Behring Allen Jeffrey 3, 15 MD Research Funding Axcelacare *Amato Anthony NA MD Advisory Committee Novarits *Amato Anthony NA MD Advisory Committee Akshi *Amato Anthony NA MD Advisory Committee Biogen *Amato Anthony NA MD Consultant Best Doctor Badger Gary 2, 204 MS Research Funding Nufactor. Barohn Richard 2, 204 MD Honoraria Grifols Barohn Richard 2, 204 MD Honoraria Genzyme Barohn Richard 2, 204 MD Consultant Speakers Bureau NuFactor Barohn Richard 2, 204 MD Editor Neurology Clinics of North America Barohn Richard 2, 204 MD Research Funding Cytokenetics. Bennett Ralph 93 M.D. Research Funding Allergan Pharmaceuticals CohenWolkowiez Michael 6 MD, PhD Consultant Jacobus Pharmaceutical Company, Inc. *Desai Urvi NA MD Speakers Bureau UCB Dimachkie Mazen 2, 204 MD Consultant, Advisory Committee Pfizer Dimachkie Mazen 2, 204 MD Consultant, Advisory Committee Depomed Dimachkie Mazen 2, 204 MD Consultant, Advisory Committee Merck Dimachkie Mazen 2, 204 MD Consultant, Advisory Committee CSL-Behring Dimachkie Mazen 2, 204 MD Consultant, Advisory Committee Nufactor Dimachkie Mazen 2, 204 MD Consultant, Advisory Committee Biomarin Dimachkie Mazen 2, 204 MD Consultant, Advisory Committee Baxter Dimachkie Mazen 2, 204 MD Consultant, Advisory Committee Catalyst Gelinas Deborah 3 MD Employee Grifols Gorson Kenneth 3 MD Research Funding Grifols Gorson Kenneth 3 MD Research Funding Grifols Greer Michelle 2, 204 RN Employee NuFACTOR Specialty Pharmacy Guptill Jeffrey 6 MD, MA, MHS Consultant Jacobus Pharmaceuticals and was an investigator in the DAPPER trial. Guptill Jeffrey 6 MD, MA, MHS Investigator DAPPER trial Jacobus David 6 NA Employee Jacobus Pharmaceutical Company, Inc. Jacobus Laura 6 NA Employee Jacobus Pharmaceutical Company, Inc Katz Jonathan 2, 204 MD Research Funding Blue Cross Katz Jonathan 2, 204 MD Research Funding Grifols Katz Jonathan 2, 204 MD Clinical Trials PI Teva Katz Jonathan 2, 204 MD Clinical Trials PI Synapse Katz Jonathan 2, 204 MD Research Funding Blue Cross, Grifols, Clinical trials PI: Teva, Synapse Katz Jonathan 2, 204 MD Research Funding Blue Cross, Grifols, Clinical trials PI: Teva, Synapse Katz Jonathan 2, 204 MD Research Funding Blue Cross, Grifols, Clinical trials PI: Teva, Synapse Katzin Lara 2, 204 MD Speakers Bureau Grifols Katzin Lara 2, 204 MD Consultant NuFactor Levine Todd 2, 204 MD Research Funding Grifols Levine Todd 2 MD Research Funding Baxter Levine Todd 2 MD Research Funding Nufactor Levine Todd 2, 204 MD Financial Interest Corinthian Reference Labs Levine Todd 204 MD Speaker Baxalta Levine Todd 204 MD Consultant Questcor Levine Todd 204 MD Financial Interest Mallinkrodt McIlduff Courtney 11, 115 MD, MMSc Research Funding NIH grants K24NS060951 and F32DC014382. Mozaffar Tahseen 2, 204 MD Speaker, Advisory Board Member, Research Funding Genzyme Corporation Mozaffar Tahseen 2, 204 MD Speaker, Research Funding Grifols Mozaffar Tahseen 2, 204 MD Advisory Committee Amicus Mozaffar Tahseen 2, 204 MD Advisory Committee Biogen idec Mozaffar Tahseen 2, 204 MD Advisory Committee Idera Pharmaceuticals Mozaffar Tahseen 2, 204 MD Advisory Committee Ultragenyx Mozaffar Tahseen 2, 204 MD Research Funding Cytokinetics Mozaffar Tahseen 2, 204 MD Research Funding Alexion Mozaffar Tahseen 2, 204 MD Research Funding Biomarin Mozaffar Tahseen 2, 204 MD Research Funding GSK Mozaffar Tahseen 2, 204 MD Research Funding Ultragenyx Mozaffar Tahseen 2, 204 MD Research Funding Novartis Phan Han 127 MD Consultant Sarepta Therapeutics Phan Han 127 MD Advisory Committee Biomarin Phan Han 127 MD Advisory Committee Marathon Therapeutics Ritt Elissa 2 MAS Employee NuFACTOR Specialty Pharmacy Rutkove Seward 11, 115 MD Ownership Interest Consultant, Advisory Committee Skulpt, Inc. Saperstein David 2 MD Speakers Bureau Grifols Saperstein David 2 MD Speakers Bureau Baxter Saperstein David 2, 204 MD Consultant NuFactor Saperstein David 2, 204 MD Ownership Interest Corinthian Reference Lab Saperstein David 204 MD Speakers Bureau Baxalta Serrano Daniel 3 PhD Research Funding Grifols Serrano Daniel 3 PhD Research Funding National Headache Foundation from Allergan inc. Serrano Daniel 3 PhD Research Funding Ortho-McNeil Serrano Daniel 3 PhD Research Funding Colucid Serrano Daniel 3 PhD Research Funding Endo Pharmaceuticals Serrano Daniel 3 PhD Research Funding GlaxoSmithKline Serrano Daniel 3 PhD Research Funding MAP Pharmaceuticals Serrano Daniel 3 PhD Research Funding Merck & Co. Inc. Serrano Daniel 3 PhD Research Funding NuPathe Serrano Daniel 3 PhD Research Funding Novartis Ubogu Eroboghene 153,184 M.D. Research Funding NIH Ubogu Eroboghene 153,184 M.D. Royalties Baylor Licensing Group Ubogu Eroboghene 153,184 M.D. Royalties Springer Science and Business Media Uribe Juan 145 MD Consultant Nuvasive Vaughan Leslie 2, 204 RPh Employee NuFACTOR Specialty Pharmacy *Walker Francis NA MD Interest Free Loans Natus *Walker Francis NA MD Interest Free Loans Terason Wolfe Gil 2, 204 MD Speakers' Bureau Member, Advisory Committee Grifols Wolfe Gil 2, 205 MD Advisory Committee Baxtar